---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-26-000003"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2026-01-14T23:59:59+00:00"
generated_at: "2026-05-16T10:18:56.748418+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Intuitive Surgical Q4 2025 revenue $2.87B, up 19% YoY; procedures grow 18%

## Summary
- Revenue $2.87B in Q4 (+19% YoY); full year $10.06B (+21%).
- Worldwide da Vinci procedures +17% in Q4, +18% full year; Ion procedures +44% Q4, +51% FY.
- Placed 532 da Vinci systems in Q4 (+8% YoY), including 303 da Vinci 5 systems (up from 174).
- 2026 da Vinci procedure growth guidance 13-15%.
- Full year da Vinci procedures exceeded 3.15 million; U.S. general surgery +18%.

## SEC filing metadata
- accession: 0001035267-26-000003
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2026-01-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000003/0001035267-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000003/isrg-20260114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-26-000003
- JSON: https://secwatch.observer/filing/0001035267-26-000003.json
- Plain text: https://secwatch.observer/filing/0001035267-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.